Pembroke Pines, Florida Patent of the Year – 2024/2025
Poseidon Medical Inc. has been awarded the 2024/2025 Patent of the Year for its innovative vascular prosthesis designed to treat complex arterial bifurcations. Their invention, detailed in U.S. Patent Application No. 20240277498, titled ‘Support for treating vascular bifurcations’, employs a hybrid stent structure combining biostable and biodegradable components to support vessel branches while minimizing long-term implant presence.
The prosthesis features a radially expansible support deployed within a branch artery and a bifurcation traversing segment extending into the main artery. This segment comprises a biostable portion connected to a biodegradable portion, allowing temporary scaffolding that degrades over time. Such design aims to maintain vessel patency during healing and reduce complications associated with permanent implants.
This approach addresses challenges in treating bifurcated lesions, particularly in patients with critical limb ischemia (CLI), where preserving blood flow is crucial. By providing structural support during the critical healing phase and then resorbing, the device reduces the risk of long-term complications.
Poseidon Medical Inc., led by founder and CEO Richard Davis, focuses on developing advanced medical devices to improve vascular interventions. Their commitment to innovation is evident in this latest patent, which holds promise for enhancing patient outcomes in complex vascular procedures.